Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

Upadacitinib effectively treated alopecia areata when other treatments failed.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

The hair loss is likely due to a fade haircut.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tiny particles called anionic squarticles can effectively remove a common antidepressant from the body after an overdose.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Ruxolitinib can cause a delayed skin reaction on the nose.

Drug misuse can cause serious eye infections and other severe side effects.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

JAK inhibitors can cause severe acne, limiting their use for hair regrowth.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Onabotulinumtoxin-A injections significantly improved scalp pain in a patient with trichodynia.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.